Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is the most common causative agent of acute bacterial skin and skin-structure infections (ABSSSI), one of the major challenges to the health system worldwide. Although the use of antibiotics as the first line of intervention for MRSA-infected wounds is recommended, important side effects could occur, including cytotoxicity or immune dysregulation, thus affecting the repair process. Here, we show that the oxazolidinone antibiotic linezolid (LZD) impairs wound healing by aberrantly increasing interleukin 1 β (IL-1β) production in keratinocytes. Mechanistically, LZD triggers a reactive oxygen species (ROS)-independent mitochondrial damage that culminates in increased tethering between the endoplasmic reticulum (ER) and mitochondria, which in turn activates the NLR family pyrin domain-containing 3 (NLRP3) inflammasome complex by promoting its assembly to the mitochondrial surface. Downregulation of ER-mitochondria contact formation is sufficient to inhibit the LZD-driven NLRP3 inflammasome activation and IL-1β production, restoring wound closure. These results identify the ER-mitochondria association as a key factor for NLRP3 activation and reveal a new mechanism in the regulation of the wound healing process that might be clinically relevant.

Details

Title
ER-mitochondria association negatively affects wound healing by regulating NLRP3 activation
Author
Licini, Caterina 1 ; Morroni, Gianluca 2 ; Lucarini, Guendalina 1 ; Vitto, Veronica Angela Maria 3   VIAFID ORCID Logo  ; Orlando, Fiorenza 4 ; Missiroli, Sonia 3   VIAFID ORCID Logo  ; D’Achille, Gloria 2 ; Perrone, Mariasole 3   VIAFID ORCID Logo  ; Spadoni, Tatiana 5 ; Graciotti, Laura 5   VIAFID ORCID Logo  ; Bigossi, Giorgia 6   VIAFID ORCID Logo  ; Provinciali, Mauro 6 ; Offidani, Annamaria 7 ; Mattioli-Belmonte, Monica 8 ; Cirioni, Oscar 9 ; Pinton, Paolo 3   VIAFID ORCID Logo  ; Simonetti, Oriana 7 ; Marchi, Saverio 8   VIAFID ORCID Logo 

 Marche Polytechnic University, Department of Clinical and Molecular Sciences, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210) 
 Marche Polytechnic University, Microbiology Unit, Department of Biomedical Sciences and Public Health, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210) 
 University of Ferrara, Department of Medical Sciences, Laboratory for Technologies of Advanced Therapies (LTTA), Ferrara, Italy (GRID:grid.8484.0) (ISNI:0000 0004 1757 2064) 
 Scientific Technological Area, IRCCS INRCA, Experimental Animal Models for Aging Research, Ancona, Italy (GRID:grid.8484.0) 
 Marche Polytechnic University, Department of Biomedical Sciences and Public Health, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210) 
 IRCCS INRCA, Advanced Technology Center for Aging Research, Ancona, Italy (GRID:grid.7010.6) 
 Marche Polytechnic University, Clinic of Dermatology, Department of Clinical and Molecular Sciences, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210) 
 Marche Polytechnic University, Department of Clinical and Molecular Sciences, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210); IRCCS INRCA, Advanced Technology Center for Aging Research, Ancona, Italy (GRID:grid.7010.6) 
 Marche Polytechnic University, Clinic of Infectious Diseases, Department of Biomedical Sciences and Public Health, Ancona, Italy (GRID:grid.7010.6) (ISNI:0000 0001 1017 3210) 
Pages
407
Publication year
2024
Publication date
Jun 2024
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3066598917
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.